[Treatment of circulatory encephalopathy with Cavinton].
Lebedeva
N V
NV
NII of Neurology RAMN, Moscow.
Chukhrova
V A
VA
Solov'ev
O U
OU
Nepesov
R R
RR
D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000503:physiopathology; D004333:Drug Administration Routes; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014748:Vinca Alkaloids / Q000008:administration & dosage / Q000627:therapeutic use*
D014665:Vasodilator Agents; D014748:Vinca Alkaloids; C013983:vinpocetine
Lechenie bol'nykh distsirkuliatornoí 'entsephalopatieí preparatom Kavinton.